NGM Biopharmaceuticals Inc (NASDAQ:NGM)
| 5.11 BATS BZX Real-Time Price As of 3:37pm ET |  -0.07 / -1.35%Today’s Change | 2.92 Today|||52-Week Range 18.25 | +1.79% Year-to-Date |
Institutional investors purchased a net $11.5 million shares of NGM during the quarter ended March 2019. This may signal that the smart money is gaining interest in this company as the 43.87% of the shares outstanding that institutional investors hold is among the lowest in the Biotechnology industry.
| Individual stakeholders | 34.58% |
| Other institutional | 30.25% |
| Mutual fund holders | 13.63% |
Largest Quarterly Institutional
Transactions
Latest Institutional Activity
| 12/31/2022 | DIVERSIFIED TRUST CO. Bought 12.9 Thousand shares of NGM Biopharmaceuticals In... |
| 10/31/2022 | BG FUND MANAGEMENT LUXEMBOURG SA Bought 10.0 Thousand shares of NGM Biopharmaceuticals In... |
| 12/31/2022 | T. ROWE PRICE INTERNATIONAL LTD. Bought 3.0 Thousand shares of NGM Biopharmaceuticals In... |
Top 10 Owners of NGM Biopharmaceuticals Inc
| Stockholder | Stake | Shares owned | Total value ($) | Shares bought / sold | Total change |
|---|---|---|---|---|---|
| Ecor1 Capital LLC | 7.87% | 6,435,518 | 32,306,300 | +5,894,410 | +1,089.32% |
| Fidelity Management & Research Co... | 5.12% | 4,186,777 | 21,017,621 | +2,126,738 | +103.24% |
| The Vanguard Group, Inc. | 4.68% | 3,823,445 | 19,193,694 | +494,742 | +14.86% |
| BlackRock Fund Advisors | 3.74% | 3,058,965 | 15,356,004 | +71,412 | +2.39% |
| Avidity Partners Management LP | 2.20% | 1,798,100 | 9,026,462 | +1,798,100 | -- |
| First Light Asset Management LLC | 1.17% | 955,505 | 4,796,635 | -180,379 | -15.88% |
| Rubric Capital Management LP | 1.07% | 877,161 | 4,403,348 | +79,573 | +9.98% |
| SSgA Funds Management, Inc. | 1.05% | 855,575 | 4,294,987 | +85,133 | +11.05% |
| Logos Global Management LP | 1.04% | 850,000 | 4,267,000 | +850,000 | -- |
| Dimensional Fund Advisors LP | 0.96% | 787,808 | 3,954,796 | +141,090 | +21.82% |
Top 10 Mutual Funds Holding NGM Biopharmaceuticals Inc
| Mutual fund | Stake | Shares owned | Total value ($) | Shares bought / sold | Total change |
|---|---|---|---|---|---|
| Vanguard Total Stock Market Index... | 1.55% | 1,269,403 | 6,372,403 | 0 | 0.00% |
| Vanguard Small Cap Index Fund | 1.42% | 1,158,434 | 5,815,339 | +122,286 | +11.80% |
| iShares Russell 2000 ETF | 1.11% | 903,940 | 4,537,779 | -9,455 | -1.04% |
| Vanguard Small Cap Value Index Fu... | 0.99% | 810,207 | 4,067,239 | +91,866 | +12.79% |
| Vanguard Extended Market Index Fu... | 0.66% | 541,140 | 2,716,523 | -1,084 | -0.20% |
| AXA Framlington Biotech Fund | 0.47% | 385,571 | 1,935,566 | +7,976 | +2.11% |
| TIAA-CREF Quant Small Cap Equity ... | 0.39% | 316,340 | 1,588,027 | -4,790 | -1.49% |
| Fidelity Small Cap Index Fund | 0.39% | 314,439 | 1,578,484 | +8,783 | +2.87% |
| iShares Biotechnology ETF | 0.38% | 314,007 | 1,576,315 | +1,180 | +0.38% |
| BlackRock Advantage Small Cap Cor... | 0.33% | 269,105 | 1,350,907 | 0 | 0.00% |